EFFECT CASSIA AURICULATA ON LIPID PEROXIDATION AND LIPIDS IN STREPTOZOTOCIN - NICOTINAMIDE INDUCED DIABETIC RATS

Main Article Content

Pidaran Murugan

Keywords

lipids, lipid peroxidation, Cassia auriculta  flower extract, Cassia auriculta leaf extract

Abstract

Introduction: The present study investigated the beneficial effect of Tanner’s cassia Cassia auriculta  flower extract (CFEt) and leaf extract (CLEt) on lipid peroxidation and lipids properties in streptozotocin (STZ) –induced diabetic rats.


Methods: The effects of an aqueous extract of CFEt (0.45 g/kg), CLEt (0.45 g/kg) and  glybenclamide on plasma glucose, insulin,  thiobarbituric acid reactive substances (TBARS) and hydroperoxides formation, cholesterol, triglycerides, free fatty acids and phospholipids, histopathological examination of liver and kidney section of  normal and experimental groups.


Results: Oral administration of CFEt and CLEt (0.45 g/kg) aqueous extract and glibenglamide to diabetic rats for 45 days significantly resulted in significant reduction in blood glucose and significant increase in plasma insulin levels. In addition, CFEt at (0.45 g/kg) and CLEt (0.45 g/kg) significantly decreased the levels of serum and tissue lipids as compared to untreated diabetic rats, with significant decrease in thiobarbituric acid reactive substances (TBARS) and hydroperoxides formation in serum, liver and kidney, suggesting its role in protection against lipid peroxidation induced membrane damage.


Conclusion: CFEt and CLEt has beneficial effect on plasma insulin and blood glucose level. Moreover it was a prevention of lipid metabolism defects could represent a protective mechanism against the development of atherosclerosis. The CFEt administration showed more effective than CLEt and glibenclamide.

Abstract 193 | pdf Downloads 106

References

1. Al-Shamaony L, Al-Khazraji SM, Twaij HA. (1994). Hypoglycaemic effect of Artemisia herba alba II. Effect of a valuable extract on some blood parameters in diabetic animals. J Ethnopharmacol. 43: 167-171.
2. Bishayee A, Chatterjee M. (1994). Hypolipidaemic and antiatherosclerotic effects of oral Gymnema sylvestre R. Br. leaf extract in albino rats fed a high fat diet. Phytother Res. 8: 118-120.
3. Bopanna KN, Kannan J, Sushma G, Balaraman R, Rathod SP. (1997). Antidiabetic and antihyperlipidemic effects of Neem seed kernel powder on alloxan diabetic rabbits. Ind J Pharmacol. 29: 162-167.
4. Brahmachari HB, Augusti KT. (1961). Hypoglycaemic agents from indigenous plants. J. Pharm. Pharmacol. 13: 381-385.
5. Brownlee M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature. 414: 813-820.
6. Cohn RM, Roth KS. (1996). Lipid and lipoprotein metabolism. Biochemistry and disease, Williams and Wilkins Publishers, Baltimore. 280.
7. Devendra D, Eisenbarth GS. (2003). Immunologic endocrine disorders. J Allergy Clin Immunol. 111: S624-S636.
8. Duncan, BD (1957). Multiple range test for correlated and heteroscedastic means. Biometrics. 13, 359-364.
9. Falholt, K., W. Falholt & B. Lund. (1973). An assay colorimetric method for routine determination of free fatty acids in plasma. Clin. Chim. Acta. 46, 105-111.
10. Folch J, M. Lees SGH. Solane. (1957). A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem. 226, 497-509.
11. Foster, J.B & Dunn, R.T : Stable reagents for determination of serum triglyceride by colorimetric condensation method. Clin. Chim. Acta. 1973, 19, 338-340.
12. Fraga CG, Leibouitz BE, Toppel A. Lipid peroxidation measured as TBARS in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med, 4: 155-161.
13. Gandhi HR. (2001). Diabetes and coronary artery disease: Importance of risk factors. Cardiol Today. 1: 31-34.
14. Halim Eshrat M, Hussain A. (2002). Hypoglycemic, hypolipidemic and antioxidant properties of combination of curcumin from curcuma longa, linn, and partially purified product from abroma augusta, Linn. in streptozotocin induced diabetes. Ind J Clin Biochem17, 33-43.
15. Jain, S.R Preventive effects of Cassia auriculata L. flowers on brain lipid peroxidation in rats treated with streptozotocin. Planta. Medica., 1: 43-47. (1968).
16. Jiang ZY, Hunt JV, Wolft SD. (1992). Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxides in low density lipoprotein. Anal. Biochem. 202: 384-389.
17. John A, Lott Turner K. (1975). Evaluation of trinder’s glucose oxidase method for measuring glucose in serum and urine. Clin. Chem. 21/12: 1754-1760.
18. Kameswara Rao, B, Appa Rao CH. (2001). Hypoglycemic and antihyperglycemic activity of alternifolium (Wt.) Walp. Seed extracts in normal and diabetic rats. Phytomedicine. 8: 88-93.
19. Masiello P, Broca C, Gross R, Roye M, Manteghetti M, Hillaire-Buys D, Novelli M, Ribes G. (1998). Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes. 47: 224-229.
20. Murugan P. (2015b) Effect of Cassia auriculata l on erythrocyte membrane bound enzymes andantioxidant status in experimental diabetes. Inter J Recent Advan Multidisci Res. 2: 5760-5764.
21. Murugan P. (2015a) Effect of Cassia auriculata L on plasma antioxidants in streptozotocinnicotinamide induced experimental diabetes. Internat J Inform Res Rev. 05: 6930-6934.
22. Murugan P. (2015c) Preventive effects of Cassia auriculata on brain lipid peroxidation streptozotocin diabetic rats. Internat J Inform Res Rev. 05: 6924-6929.
23. Murugan P. (2010). Taner’s Cassia (Cassia auriculata L) extract prevents hemoglobin glycation tail tendon collagen properties in experimental diabetic rats. J cell tissue res. 10 (1): 2109-2114.
24. Pari L, Murugan P. (2007). Influence of Cassia auriculata flowers on Insulin Receptors in Streptozotocin Induced Diabetic Rats: Studies on Insulin Binding to Erythrocytes. African J Biochem Res. 1 (7): 148-155.
25. Pushparaj P, Tan CH, Tan BK. (2000). Effects of Averrhoa bilimbi leaf extract on blood glucose and lipids in streptozotocin-diabetic rats. J Ethnopharmacol. 72: 69-76.
26. Segal P, Bachorik PS, Rifkind BM, Levy RI. (1984). Lipids and dyslipoproteinemia. In : Clinical diagnosis and management by laboratory methods, Bernard JH, Nelson DA, Tomar RH, Washington JA, Saunders WB eds. 17th ed, Philadelphia. 180-203.
27. Shigematsu N, Asaano R, Shimosaka M, Okazaki M. (2001). Evaluation of safety and efficacy for food supplement containing chitosan and Gymnema extract. Health Sci 17: 153-162.
28. Shrotri DS, Aiman R. (1960). The relationship of the post-absorptive state to the hypoglyceamic action. Ind J Med Res. 48: 162 – 168, 1960.
29. Siddique O, Sun Y, Lin JC, Chien YW. (1987). Facilitated transdermal transport of insulin. J Pharm Sci. 76: 341-345.
30. Suresh Babu P, Srinivasan K. (1997). Hypolipidaemic action of Curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem. 166: 169-175.
31. WHO (World Health Organization). (1980). Expert Committee on diabetes mellitus, Second Report of the WHO Expert Committee on Diabetes mellitus. Technical Report Series. Geneva , 646: 66.
32. Zilversmit BB, Davis AK. (1950). Micro determination of plasma phospholipids by TCA precipitation. J Lab Clin Med. 35, 155-160.
33. Zimmet P, Alberti KG, Shaw J. (2001). Global and societal implications of the diabetes epidemic. Nature. 414: 782-787.
34. Zlatkis A, Zak B, Boyle GJ. A method for the determination of serum cholesterol. J Clin Med. 1953; 41, 486-492.